DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
US Food and Drug Administration (FDA).
FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment, another achievement in administration's fight against pandemic.
Accessed December 10, 2022 at:
https://www.Fda.gov/news-events/press-announcements/fda-issuesemergency-use-authorization-convalescentplasma-potential-promising-covid-19-treatment
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.